Approx. read time: 84 min.
Post: I Thought Weed Would Help Me Escape: My Eye-Opening Battle With Cannabis Hyperemesis Syndrome
I Thought Weed Would Help Me Escape—Boy, Was I Wrong
This past weekend changed my entire perspective on cannabis. As someone juggling a busy life, family responsibilities, and personal mental health challenges, I thought lighting up would be an innocent escape, a form of relief. But what I experienced was the complete opposite—it turned into a frightening spiral that landed me in agony.
I’ve always heard people say, “Weed helps you chill,” and honestly, I believed that for the longest time. Whether you’re dealing with anxiety, stress, or just needing to check out mentally for a while, cannabis is often painted as a safe harbor. But let me tell you something that every parent, every recreational user, and especially every long-term cannabis consumer needs to know: Cannabis Hyperemesis Syndrome (CHS) is real. And I lived through it.
What Is Cannabis Hyperemesis Syndrome (CHS)?
Cannabis Hyperemesis Syndrome, or CHS, is a lesser-known but very real condition that causes severe nausea, vomiting, and abdominal pain. According to Cedars-Sinai Medical Center, it usually affects long-term, daily users of marijuana, with symptoms sometimes appearing 10 to 12 years after chronic use.
What’s bizarre is that cannabis is typically known to reduce nausea, especially for chemo patients. But when it’s overused—especially over long periods—it flips the script. Instead of helping, it can completely wreck your digestive system. It’s like your body says, “Enough.”
My Experience: When Relaxation Turned Into Chaos
It started with some early morning nausea—subtle at first. I brushed it off. Maybe I was just tired, hadn’t eaten properly, or had too much coffee. But by mid-afternoon, the vomiting kicked in—intense, uncontrollable, relentless. No food stayed down. I felt dizzy, weak, and disoriented.
Then came the abdominal pain, the kind that grips you so hard you can’t sit still or lie down. I took a hot shower just to find some comfort. And that’s when something clicked.
I remembered reading that hot showers temporarily relieve symptoms of CHS. That was my red flag.
The 3 Phases of CHS—and Where I Landed
Doctors categorize CHS into three phases:
-
Prodromal Phase: You feel nauseous in the mornings and may have a fear of vomiting. Users often increase cannabis intake, thinking it helps.
-
Hyperemetic Phase: This is where I found myself. Nonstop vomiting, stomach pain, weight loss, and compulsive hot showers.
-
Recovery Phase: Symptoms fade once you stop cannabis use. But guess what? If you start again, it comes right back.
This isn’t some fringe phenomenon. CHS is real, underdiagnosed, and extremely debilitating.
How It’s Diagnosed and Treated
Diagnosing CHS can be tricky because it mimics other conditions like food poisoning or gastrointestinal infections. My symptoms were so severe that I considered going to the ER. Diagnosis typically involves:
-
Drug use history
-
Blood tests
-
Electrolyte levels
-
Abdominal imaging
-
Ruling out other diseases
Treatment often includes:
-
IV fluids for dehydration
-
Antiemetic medications (to stop vomiting)
-
Hot showers
-
Capsaicin cream on the abdomen (similar effect to heat therapy)
But the only true cure? Stop using marijuana altogether. And that’s the hardest truth to swallow for many.
CHS Complications Can Be Deadly
If you think vomiting is just uncomfortable, think again. Untreated CHS can lead to:
-
Dehydration
-
Electrolyte imbalance
-
Esophageal tears
-
Seizures
-
Kidney failure
-
Heart arrhythmias
-
In rare cases, even brain swelling
And for what? A high that was supposed to help you “escape” but ends up making you a prisoner of your own body?
Final Thoughts: Awareness Can Save Lives
I’m not here to shame anyone. Cannabis, like anything else, has its place—when used responsibly and with awareness. But too often, we treat it like it’s harmless, especially when used to cope with stress, trauma, or mental health issues. That’s where the danger creeps in.
Parents, talk to your kids about this.
Users, listen to your bodies.
Daily consumers, understand that the more you use it, the greater your risk for CHS.
If this story saves even one person from the suffering I went through this weekend, it’s worth telling.
Cannabis Hyperemesis Syndrome (CHS) is a paradoxical illness seen in long-term, frequent marijuana users, causing recurrent bouts of severe nausea, vomiting, and abdominal pain【17†L161-L169】【42†L83-L91】. It might sound counterintuitive – after all, cannabis is often known for
** effects – yet CHS flips the script, leading to what some have dubbed “the marijuana vomiting syndrome.” This comprehensive report explores CHS in detail, from its causes and symptoms to diagnosis, treatment, and prevention, with a cautionary tone aimed at users, medical professionals, and concerned families.
【2†embed_image】 Cannabinoid Hyperemesis Syndrome in
arizing pathophysiology, key diagnostic criteria, phases, and treatments (Source: Sanché Mabins, Cook County Health). Long-term cannabis use can alter the body’s response to the drug, ultimately triggering cycles of intense vomiting despite marijuana’s usual antiemetic reputation【17†L187-L195】【25†L275-L283】. CHS typical
in people who have used cannabis heavily for years** (often daily for a decade or more)【17†L161-L169】【42†L83-L91】. Researchers first identified CHS in 2004 in Australia, and cases have since risen with the increasing prevalence and potency of cannabis worldwide【31†L109-L117】【23†L236-L244】
uide, we break down the syndrome’s three phases (prodromal, hyperemetic, recovery), examine why it happens, discuss h
and treat it, and provide global insights, statistics, and prevention strategies.
What is Cannabis Hyperemesis Syndrome?
Cannabis Hyperemesis Syndrome (CHS) is a condition in which a person experiences repe
of intractable nausea and vomiting due to long-term, high-frequency cannabis use【17†L161-
L140】. It is considered a form of cyclic vomiting disorder triggered specifically by cannabis. CHS occurs exclusively in people with
chronic marijuana use, especially those using daily or multiple times a week over long periods【17†L177-L180】【4†L81-L84】. It often takes years of heavy use before CHS first appears – one hospital observed symptoms after an average of 10–12 years of cannabis use【17†L161-L169】. Unlike the well-known a
efits of cannabis in conditions like chemotherapy-related nausea, CHS is a paradoxical reaction where the same drug causes relentless vomiting.
Causes: The exact cause of CHS remains under investigation, but it is linked to **physiological changes from prolonged
Tetrahydrocannabinol (THC), the primary psychoactive component of cannabis, acts on cannabinoid receptors (CB1 re
both in the brain and the digestive tract【17†L169-L175】. Over time, heavy cannabis use may lead to desensitiza
ulation of these receptors. In the brain, THC initially suppresses nausea (hence its medical use as an antiemetic), but chronic use might cause the brain to stop responding in the same way, reversing marijuana’s anti-nausea effects【17†L187-L195】. Meanwhile, in the gut, THC continuously binding to receptors can slow gastric emp
ct the esophagus and digestion, promoting nausea and reflux【17†L169-L175】【31†L117-L125】. Rese
cribe a “biphasic” effect of cannabinoids: low doses curb nausea, but high chronic doses can trigger nausea and vomiting【15†L130-L139】. Essentially, long-term cannabis use “flips the switch” – the body’s respon
from antiemetic to pro-emetic. Genetic factors may also make some individuals more susceptible; for example, atypical cannabinoid metabolism or variations in receptors could predispose certain people to develop CHS while others never do【37†L273-L282】【37†L287-L295】. It remains unclear why only some heavy marijuana users get CHS and others do not【17†L196-L199】,
examining differences in metabolism, receptor genetics, and other risk factors.
Who is affected: CHS is notoriously associated with long-term, frequent cannabis users – typically those who consume marijuana at least weekly,
ly【17†L177-L180】. Many patients are young adults who began using in their teens or early twenties and continued for years. Heavy use is the key risk factor, and cases have been reported in both recreational and medicinal users of cannabis. There is a notable
– studies indicate around 72–73% of CHS cases occur in males【4†L81-L84】 – though it can affect any gender. The typical age range is 18 to 40 years old, aligning with the demographic of frequent cannabis users【31†L103-L110】. CHS has been observed across different ethnicities and regions, anywhere cannabis use is common. Importantly, only stopping cannabis use can prevent CHS episodes; continued use will perpetuate the cycle【33†L315-L324】【19†L229-L237】.
Phases and Symptoms of CHS
CHS symptoms tend to follow a cyclical pattern. Healthcare providers often divide the syndrome’s course into three phases: the prodromal phase, the hyperemetic phase, and the recovery phase【17†L201-L209】. Each phase has distinctive features:
Prodromal Phase (Pre-Vomiting)
In the prodromal phase, **early warning
e, though they can be subtle. The person may experience persistent morning nausea, occasional stomach pain, and a fear or anxiety about vomiting【17†L207-L215】【35†L208-L216】. Symptoms are milder in this stage and no severe vomiting has started yet. Often, the individual still eats normally, though they might feel queasy especially after waking up【17†L207-L215】. Para
y people in this phase increase their cannabis use under the bel
rijuana will settle their stomach (since it used to help their nausea)【17†L207-L215】. This self-treatment actually perpetuates the cycle. The prodromal phase can last months or even years【17†L207-L215】. Because the symptoms are not acute, individuals might not
stage. They may not realize these intermittent nausea bouts are related to cannabis. There are usually no com
athing behaviors yet in this phase (those come later once vomiting hits). This phase is essentially the calm before the storm, and unfortunately many continue regu
ngly setting the stage for the next phase.
Hyperemetic Phase (Vomiting Crisis)
The hyperemetic phase is when CHS fully manifests. It is characterized by unrelen
episodes of vomiting (hyperemesis), and intense abdominal pain【17†L213-L221】【35†L219-L228】. Vomiting can
and frequent** – patients often retch or vomit multiple times per hour, unable to keep food down. The bouts of
last for 24–48 hours or even days at a time【35†L219-L227】. People in this phase often stop eating and drinking voluntarily because of severe nausea and fear that any intake will provoke vomiting【35†L219-L227】. Weight loss and dehydration are common as a result【35
also develop abdominal tenderness or pain that can be quite severe【17†L213-L221】. A distinctive behavior in this phase is compulsive hot bathing or showering. Patients discover that hot showers or baths dramatically relieve their nausea and abdominal pain, albeit temporarily【19†L220-L228】【35†L229-L237】. They may spend hours in
nd often describe the relief as “temperature-dependent” – the hotter the water, the more the symptoms ease【35†L229-L237】. This behavior is so characteristic that it serves as a clinical clue for CHS: many as 50% or more of CHS patien
ers【2†L0-L0】【19†L271-L279】. (The likely reason is that heat stimuli trigger certain receptors (TRPV1) and the brain’s hypothalamus, which can modulate the vomiting reflex and pain sensation, essentially “distracting” the brain from nausea signals【23†L256-L264】.) During the hyperemetic phase, individuals are usually miserable and incapacitated – unable to work or go about normal life – and often seek medical care due to the uncontrolled vomiting. It is at this stage that most patients end up in emergency departments, sometimes confused with a stomach bug or other acute illness. The hyperemetic phase continues until cannabis use is completely stopped【19†L229-L237】. If the person does not quit, they can cycle in and out of this phase repeatedly. Epi
eeks or months, often triggered by resumption of cannabis or stress.
Recovery Phase (Resolution)
The recovery phase of CHS begins once the individual abstains from cannabis and the acute vomiting episode resolves【19†L229-L237】. During recovery, symptoms gradually go away and normal appetite returns【19†L232-L239】. This phase can last from days to months, depending on how long the person remains cannabis-free and how quickly their body readjusts【
n report feeling significantly better within about 1–2 days after stopping cannabis, with steady improvement thereafter【19†L283-L291】【25†L
y can resume normal eating and hydration, and any weight lost may be regained【35†L240-L248】. Importantly, if the person uses marijuana again, the symptoms almost invariably return, usually after so
use【19†L232-L239】【35†L240-L248】. Relapse is common if the individual believes they are “cured” and can resume even moderate cannabis use – often, the cycle of nausea will start again after a latency period. During recovery, the compulsive hot bathing behavior subsides as it’s no longer needed for symptom relief【35†L240-L248】. Full recovery *requires complete cannabis
ny patients, once they have gone through the ordeal of CHS, are counseled to avoid cannabis permanently to prevent future episodes. This phase is essentially the period of healing and return to baseline health, which can be sustained indefinitely if no further cannabis is used. In some reports, patients needed a few weeks to a
abstinence for all symptoms to fully resolve【35†L240-L248】. Supportive care and counseling during this phase can help maintain abstinence and address any During recovery, the compulsive hot bathing behavior subsides as it’s no longer needed for relief【35†L240-L248】. Supportive care and counseling during this phase can help maintain abstinence and address any underlying issues (such as cannabis dependence or the original reason the person was using marijuana, like anxiety or pain). Education is crucial so that patients understand that resuming cannabis will likely cause symptoms to return【35†L244-L253】.
Summary of CHS Phases: In summary, CHS starts with a prodromal period of milder nausea, escalates into a hyperemetic crisis of vomiting and abdominal pain (often prompting medical care), and then enters a recovery period once cannabis use is halted. This cyclic nature – well periods alternating with debilitating vomiting episodes – is a hallmark of the syndrome【17†L201-L209】. Recognizing these phases can aid in diagnosis and management, a
xt.
Diagnosing CHS: A Clinical Challenge
Diagnosing Cannabis Hyperemesis Syndrome can be challenging because its symptoms mimic those of many other disorders. There is no specific lab test or marker for CHS – diagnosis is clinical, based on history and exclusion of other causes【19†L275-L279】. Physicians must have a high index of suspicion, especially in areas where cannabis use is common. Key steps in the diagnostic process include:
-
Detailed Patient History: A thorough review of the patient’s substance use is critical. Doctors should explicitly ask about cannabis use, including frequency and duration【19†L265-L273】. Often CHS patients have been using marijuana daily or nearly daily for years. Unfortunately, patients may not always volunteer this information due to stigma or not realizing it’s relevant. Cr
dgmental environment (as many emergency physicians advise) encourages honesty【8†L21-L29】. If the person meets the profile – long-term heavy cannabis use – and has cyclic vomiting, CHS is strongly suspected【19†L265-L273】.
-
Clinical Criteria: Doctors look for the characteristic features: long-term cannabis use, severe cyclic vomiting with abdominal pain, and relief of symptoms with hot showers or cessation of cannabis【19†L265-L273】. The relief with hot bathing is a telling clue (few other conditions prompt that behavior)【19†L271-L
he only way to confirm CHS is to see the patient improve after quitting cannabis, since there’s no definitive blood test【19†L275-L279】. In fact, a “diagnostic trial”
is sometimes used – if vomiting stops when cannabis is stopped, CHS is the likely diagnosis.
-
Excluding Other Causes: Because persistent vomiting has many possible causes, healthcare providers will perform tests to rule out other emergencies and disorders【19†L242-L251】. This usually includes blood tests (to check for infection, organ function, electrolyte levels), imaging like abdominal CT or ultrasound (to exclude bowel obstruction, gallbladder disease, kidney stones, etc.), and sometimes an upper endoscopy to look inside the stomach【19†L242-L251】【19†L252-L260】. Women will often get a pregnancy test, since hyperemesis gravidarum (severe vomiting in pregnancy) can mimic CHS【19†L245-L252】. Neurological causes (like brain tumors or migraines) might be evaluated with a CT scan of the head if indicated【19†L252-L260】. Typically, in CHS patients, these tests come back normal, which can further point toward a functional cause like CHS.
-
Differentiating from
ng Syndrome (CVS): CHS is often initially misdiagnosed as Cyclic Vomiting Syndrome, a disorder with similar bouts of vomiting but usually without the cannabis connection【19†L258-L264】. In fact, many CHS patients c
gnosis until the truth comes out about cannabis use【4†L91-L99】. One distinction is that CVS sufferers may or may not use cannabis, and their vomiting episodes have defined frequency criteria, whereas CHS diagnostic criteria hinge on cannabis use history and behaviors like hot bathing【4†L93-L99】. If a patient is eventual
ut using marijuana heavily, or if doctors clue in to the hot shower habit, the diagnosis often shifts to CHS. On average, studies have found a significant delay in diagnosing CHS – often over 1–2 years from symptom onset – during which patients may undergo multiple ER visits, hospital admissions, and invasive tests【4†L89-L97】【33†L321-L329】. This delay is usually due to lack of awareness and pati
cannabis use.
Because CHS was only relatively recently recognized (since the early 2000s), some healthcare providers are still unfamiliar with it【19†L258-L264】. Increasing awareness is improving diagnosis. For instance, emergency medici
in the UK in 2023 urge clinicians to consider CHS in any cyclic vomiting case with cannabis use and to pro
ation and support for quitting if CHS is suspected【8†L19-L27】【8†L31-L37】. Ultimately, an accurate d
s on recognizing the pattern (chronic cannabis use + cyclic vomiting + hot shower relief) and taking the patient’s word seriously when they report their cannabis habits and self-relief behaviors. When CHS is correctly dia
n be avoided and appropriate treatment can begin.
Treatment: Managing an Active CHS Episode and Long-Term Recovery
Immediate
ent: During an active CHS episode (the hyperemetic phase), the focus is on stabilizing the patient and relieving symptoms. The cornerstone of acute treatment is **suppo
*:
-
Rehydration: Profuse vomiting causes dehydration and electrolyte imbalances, so patients often need IV fluids to rehydrate and IV electrolyte replacements (such as potassium) if levels are low【25†L268-L276】.
ress dizziness, weakness, or kidney strain from dehydration.
-
Antiemetic Medications: Paradoxically, standard anti-vomiting drugs (antiemetics) that wor
types of nausea often have little effect in CHS. Medications like ondansetron (Zofran) or metoclopramide are commonly tried but frequently ineffective against CHS-rel
Patients typically do not respond to these conventional treatments【4†L79-L84】. Instead, some other medications have shown better results:
-
Benzodiazepines: Drugs suc
help by sedating the patient and reducing the anxiety and vomiting cycle. Sedation can break the stress-vomit feedback loop and provide relief【6†L128-L136】【6†L138-L142】. Caution is used due to their addictive potential, especially since CHS patients may have substance use issues【6†L134-L141】.
-
Haloperidol or Droperidol: These antipsychotic medications (used here
or nausea) have shown efficacy in relieving CHS vomiting in many cases【6†L126-L134】【6
Haloperidol, given intravenously, often calms vomiting when other drugs fail, as in the emergency scenario described where a patient’s nausea resolved with IV haloperidol【4†L59-L67】【4†L81-L84】. Droperidol has also been used; although formal research is limited, some ER protocols includ
6†L152-L160】. (Droperidol was previously less available due to safety concerns but is making a comeback in nausea treatment【6†L152-L160】.)
-
Topical Capsaicin: Interestingly, capsaicin cream (applied to the skin) has emerged as a novel treatment for CHS. Rubbing capsaicin (chili pepper extract) on the abdomen can stimulate the same receptors (TRPV1) activated by heat, mimicking the hot-shower effect【19†L291-L29
atients, capsaicin cream significantly reduces nausea and vomiting. It’s a simple, non-invasive therapy now recommended in many eme
S.
-
Other Medications: Doctors have experimented with various drugs: **Tricyclic antidepressants (TCAs)
een noted to help some CHS patients【25†L273-L280】 (and can be useful for prevention in chronic cases); anticholin
opolamine, antihistamines like diphenhydramine, or even NK1 antagonists like aprepitant (used for ch
iting) have been tried with mixed success【6†L130-L138】【6†L132-L140】. There’s no single guaranteed drug cure, and often a cocktail is used.
-
-
Pain Control: Abdominal
ense. Depending on severity, patients may receive pain relief medications. NSAIDs or acetaminophen are used if possible; in severe cases, opioi
ven sparingly, but clinicians try to avoid them due to the risk of worsening nausea and adding another dependency.
-
Thermal Treatment: Encouragin
nt to continue hot showers or hot baths (if feasible in the hospital) can be part of symptomatic treatment
ometimes warm blankets or heating pads are provided to simulate the effect. As mentioned, topical capsaicin can be an easier substitute for hot water immersion and has become an evidence-supported therapy【19†L291-L298】【6†L137-L140
iting is so severe that oral medications can’t be kept down, all medicines are given intravenously. Patients with uncontrolled vomiting and dehydration often require hospital admission for 24-48 hours until symptoms are under c
the hospital, they will be monitored for electrolyte disturbances (e.g., low potassium which can affect the heart) and kidney function, given continuous IV fluids, and medicated as above until the vomiting stops【25†L268-L276】【25†L270-L277】. In almost all cases, symptoms begin to improve within a day or two once cannabis use is stopped and supportive treatment is underway【19†L283-L291】.
Abstinence – The Only Definitive Cure: No matter what acute treatments are given, doctors and patients consistently find that the only way to truly resolve CHS is to sto
is entirely【25†L275-L283】. During an episode, patients are advised (and often too sick) to not consume any more marijuana. Once they recover, long-term management is complete cessation of cannabis. As Dr. Camilleri (a gastroenterologist) noted, “Ultimately, the only way to guarantee health is by totally abstaining [from cannabis]. If the patient quits, vomiting due to CHS largely subsides”【25†L273-L280】. Continued or resumed marijuana use will likely trigger another cycle of illness. Some patients ask if they can go back to using a smaller amount or a weaker cannabis product. The consensus is that even lower amounts or frequency can risk recurrence, and science hasn’t confirmed any “safe” level of use for someone who has had CHS【25†L277-L284】. Therefore, complete quitting is strongly recommended.
Long-Term Recovery and Support: After the acute phase has passed and the patient is no longer vomiting, the focus shifts to maintaining abstinence and recovering fully:
-
Patients are educated that CHS will return if they resume cannabis.
n referred to follow up with their primary care physician or a gastroenterologist and, importantly, to addiction specialists or counselors if cannabis use disorder is a conce
se many CHS sufferers used cannabis to self-medicate for other problems (such as anxiety, depression, or chronic pain), it’s important to treat those underlying issues separately. For example, if a patient used marijuana for anxiety relief, a physician might prescribe alternative anxiolytics or recommend therapy so the patient isn’t tempted to turn back to cannabis.
-
Psychological and B
herapies: Quitting cannabis after years of use can be difficult. Patients might experience withdrawal symptoms like irritability, insomnia, and cravings【25†L290-L298】. Referral to therapy can help. Cognitive Behavioral Therapy (CBT) and motivational enhancement therapy have been used to support cannabis cessation. Some patients find help in 12-step programs or support groups (like Marijuana Anonymous or other substance abuse support networks) – sharing experiences and strategies can reinforce their resolve.
-
Follow-up Medication: There is no specific medication to “prevent” CHS aside from not using cannabis. However, if needed, doctors might prescribe a low-dose antiemetic or acid suppressor to have on hand in case of mild nausea during early abstinence. In some cases, if a patient absolutely cannot stop vomiting without cannabis (a very rare scenario in chronic refractory cyclic vomiting), doctors have explored using amitriptyline or other prophylactic meds long-term【25†L273-L280】, but again, these are adjuncts and not a substitute for abstinence.
-
Nutritional support: After severe episodes, patients may be malnourished or have food aversions. Dietitians might get involved to help gradually restore a normal diet and ensure proper nutrition and hydration during recovery.
It’s worth noting that cannabis use disorder (CUD) often coexists with CHS. In fact, by definition CHS patients have been using heavily despite harm, which meets criteria for CUD. Up to 20-30% of regular marijuana users develop a use disorder【25†L299-L307】, and
by nature tend to be in that heavy-use bracket. Unfortunately, there are no highly effective medications to treat cannabis addiction at this time【25†L301-L307】. Treatment relies on counseling, behavioral interventions, and social support. Some research is ongoing into medications (like certain antidepressants or anticonvulsants) to ease cannabis withdrawal or reduce cravings, but none are standard yet. Thus, behavioral therapy and support networks are the mainstay to help CHS patients stay off cannabis for good.
Outcome: With sustained abstinence, the long-term outlook for CHS patients is excellent – they typically have no further episodes and return to completely normal health. The challenge is maintaining that abstinence. Education and follow-up are crucial. Many patients, after suffering the ordeal of CHS, are motivated to quit. In interviews, recovered patients often emphasize how much better they feel and caution others not to risk even occasional use. As one recovered CHS patient advised, “Stop completely. Don’t think continuing with small amounts will help you, because it’s not. You need to just stop”【25†L331-L339】.
Prevalence and Trends: How Common is CHS?
When
st recognized in 2004, it was thought to be extremely rare. For years, only scattered cases were reported (only 83 cases documented worldwide up to 2014【33†L319-L327】). However, as awareness has grown and cannabis use has increased, we now know CHS is more common than initially believed. Estimating prevalence is tricky because many cases go undiagnosed or unreported. There is no dedicated diagnostic code in medical records for CHS, often being logged simply as generic “vomiting”【42†L98-L105】. Still, emerging data and studies provide insight:
-
A landmark survey-based study in New York aimed to estimate CHS prevalence among frequent cannabis users. It found about 33% of heavy users (using ≥20 days/month) reported experiencing CHS-like symptoms (cyclic vomiting relieved by hot showers). Extrapolated nationally, this suggests roughly 2.7 million Americans may suffer from CHS annually【27†L317-L324】【27†L319-L327】. This shocked many clinicians, as it implied CHS might affect around one-third of very heavy cannabis users – far from a rare fluke.
-
Another
egged the overall prevalence of CHS in the general population at around 0.1%【31†L103-L110】. While that is a small percentage, consider that around 18% of Americans use cannabis at least occasionally【4†L73-L81】. Among daily or long-term users, the risk is much higher (again, up to one-third by some estimates【31†L103-L110】).
-
Demographics: CHS tends to affect younger adults most – typically ages 18–40 as noted. Adolescents can develop CHS as well, especially with the rise of high-potency cannabis and vaping allowing near-constant use by teens【23†L217-L226】【23†L229-L236】. Some pediatric hospitals now report seeing teen CHS cases on a regular basis, whereas it was virtually unseen in youth decades ago【23†L217-L224】. In terms of gender, studies show a male predominance (~70–75% male), though whether males are more biologically prone or simply more likely to be heavy users is unclear【4†L81-L85】.
-
Trends with Legalization: In places with legal recreational cannabis, CHS cases have risen substantially. For example, emergency departments in North America saw CHS visit rates double between 2017 and 2021【23†L208-L216】. Colorado, one of the earliest states to legalize marijuana, experienced a 23% increase in cannabis-related vomiting cases post-legalization in one study【28†L21-L29】. Another study of Colorado ER data (2013–2018) found vomiting-related ER visits climbed 29% after legalization, correlating with the proliferation of cannabis dispensaries【29†L342-L350】【29†L353-L358】. Nevada saw similar trends: the rate of CHS ER visits roughly doubled from about 1.1 per 100,000 people to 2.2 per 100,000 after recreational cannabis commercialization【38†L321-L329】【38†L323-L331】. These trends strongly suggest that as cannabis use becomes more widespread, CHS follows in step.
-
Healthcare Impact: In areas with heavy marijuana use, CHS has become a nota
emergency care. In fact, in Colorado, CHS is now the leading cause of marijuana-related ER visits – more common than ER visits for cannabis intoxication or anxiety reactions【42†L79-L87】. At one large hospital, doctors reported seeing 1-2 CHS patients every day in the ER【42†L99-L105】. This translates to significant healthcare costs and resource utilization. One study estimated the financial burden of CHS on the US healthcare system was rising, with thousands of ER visits annually attributable to the syndrome (though exact dollar figures are still being researched)【6†L162-L170】.
To illustrate some key statistics about CHS, see Table 1 below.
| CHS Statistic | Value / Observation |
|---|---|
| Onset after prolonged use | Typica
ears** of heavy cannabis use (often >1 year daily; ~10 years on average)【17†L161-L169】【42†L83-L91】. |
| Affected population | Long-term, frequent marijuana users; most often age 18–40; ~73% of cases are male【4†L81-L84】【31†L103-L110】. |
| Prevalence among heavy users | Up to 32–33% of very heavy cannabis users may experience CHS【27†L317-L324】【31†L103-L110】. |
| Estimated annual cases (U.S.) | ~2.75 million Americans may suffer CHS each year (extrapolated)【27†L319-L327】. |
| Trend in ER visits (North America) | 2× increase in CHS-related ER visits from 2017 to 2021【23†L208-L216】. Rising cases noted especially where cannabis is legal. |
| Unique diagnostic behavior | ~50%+ of patients use hot showers for relief during episodes【2†L0-L0】【19†L271-L279】 (a key diagnostic clue). |
| Time to diagnosis (historically) | **Delay of year
3–4 years of symptoms) before CHS is recognized【33†L321-L329】, due to misdiagnosis as other illnesses. |
| Male-to-Female ratio | Approximately 3:1 male to female predominance in reported cases【4†L81-L84】. |
| Recurrence risk | High – Symptoms almost always return if cannabis use resumes【19†L232-L239】. Only complete abstinence prevents relapse. |
| Mortality | Rare – CHS is seldom fatal if treated, but complications have led to a few reported deaths (via severe dehydration and organ failure)【37†L258-L262】. |
Table 1: Key facts and figures about Cannabis Hyperemesis Syndrome (CHS).
Globally, as cannabis use rises, CHS likely does as well. The world’s population of regular cannabis users is estimated at about 2.5–5% of people【4†L73-L81】 – that’s hundreds of millions of users – so even a small fraction developing CHS translates to many individuals. In the next section, we’ll explore how CHS is being recognized (or overlooked) in different parts of the world.
International Perspectives: CHS Beyond the U.S.
While much CHS research comes from North America (where cannabis use is high and now often legal), awareness of CHS is spreading internationally:
-
Australia: Australia is where CHS was first identified in 2004, in a case series of 19 patients that put this syndrome on the medical map【31†L109-L117】. Since then, Australia (which has a significant cannabis-using population) has reported numerous cases. Australian emergency physicians are generally aware of CHS today, especially after high-profile publications.
-
Canada: Canada legalized recreational marijuana in 2018, and since then, Canadian hospitals have noted CHS as an emerging issue. Though specific Canadian data is still developing, anecdotal reports from physicians in cities like Toronto and Vancouver indicate more patients presenting with CHS post-legalization, mirroring U.S. trends. One Canadian study prior to legalization already found cannabis was associated with cyclic vomiting cases, and experts expect an uptick. Canadian healthcare guidelines (e.g., by the Canadian Association of Emergency Physicians) now include CHS in differential diagnoses for vomiting.
-
Europe: In Europe, cannabis laws and usage rates vary by country, but CHS cases have been documented across the continent. Spain had reported at least 4 cases by 2014 and published additional ones since【33†L319-L327】. United Kingdom: The UK has had CHS case reports since the 2010s; by 2023, as we saw, a formal guideline for Emergency Departments was released to improve recognition of CHS【8†L19-L27】. This suggests UK clinicians are encountering it enough to warrant official guidance. Some UK hospitals note that CHS is still underdiagnosed – patients often go through many tests before the puzzle pieces (cannabis use + vomiting + hot baths) are put together. Italy, Germany, France: all have published case reports or small series in medical literature describing CHS in their populations【32†L5-L13】. The syndrome is likely under-recognized in countries where cannabis use, while present, is less openly discussed due to legal status. But as those countries move toward more cannabis use (medicinal or recreational), CHS is expected to appear more frequently.
-
Asia and Other Regions: Cannabis use prevalence in Asia is lower in general, but it exists and is growing in some areas. There have been isolated CHS case reports in countries like India and Japan in recent years, albeit very few. Given the illegal status in many Asian countries, users may hide their cannabis use, and doctors may not think of CHS at first. Some travelers from Western countries have been diagnosed with CHS while abroad, confusing local physicians who were unaware of the condition. This highlights a need for global medical education on CHS as cannabis use globalizes.
-
Awareness and Education: Internationally, one challenge is simply lack of awareness among healthcare providers. A patient with CHS in a country where cannabis is not widely used or is taboo might be subjected to extensive invasive testing for rare diseases while the true cause (cannabis) is overlooked. However, the spread of information via medical journals and conferences is improving knowledge. Organizations like the International Cannabinoid Research Society and various gastroenterology associations are now discussing CHS at meetings. The inclusion of CHS as a subset of cyclic vomiting in the Rome IV criteria (a global gastroenterology diagnostic standard) in 2016 also helped legitimize and disseminate the concept【37†L311-L317】.
In summary, CHS is not limited to the U.S. or places with legal weed; it has been observed anywhere chronic cannabis use occurs. But places with higher rates of use (North America, Austr
Europe) have unsurprisingly reported more cases. With cannabis use on the rise globally – both for recreational and medicinal purposes – CHS stands as a cautionary phenomenon worldwide. Countries new to liberalizing cannabis laws may see a surge in CHS cases as a consequence, emphasizing the importance of preparing healthcare systems to recognize and treat this syndrome.
Challenges in Diagnosis and Treatment
CHS poses several challenges to both patients and healthcare systems, especially in contexts of widespread cannabis use:
-
Lack of Awareness and Initial Dismissal: Many patients and even doctors are initially unaware that chronic cannabis use can cause such symptoms. Patients often cannot believe cannabis is the culprit, since they have used it for years to feel good or even to treat nausea. There is often resistance or denial – “Weed helps my stomach, it can’t be making me sick” is a common sentiment. This can lead patients to refuse to accept the diagnosis of CHS【4†L91-L99】. They may continue using cannabis in disbelief, thus continuing the cycle of illness. Similarly, some physicians, unfamiliar with CHS, might attribute the vomiting to more familiar causes and miss the cannabis connection. Overcoming this requires education – doctors need to gently convince patients of the link by explaining the paradoxical physiology and pointing to the hallmark behaviors (like hot showers) and the improvement with abstinence.
-
Stigma and Honesty Issues: In places where marijua
gal or stigmatized, patients may hide their use, leading doctors down the wrong diagnostic path. Conversely, in places where cannabis is lauded for medical benefits, patients might be offended by the suggestion that cannabis is harming them. Striking the right approach is key – clinicians aim to be nonjudgmental and factual: “We know most people tolerate cannabis well, but in some it can cause this syndrome. The good news is it’s reversible if you stop using.” Emphasizing confidentiality (especially in illegal settings) can help patients open up about their habit【8†L21-L29】.
-
Diagnostic Overlap: As mentioned, CHS gets mistaken for gastrointestinal disorders (ulcers, gastritis, gallbladder attacks), eating disorders, pregnancy-related vomiting
tric illness. Some CHS patients undergo multiple expensive tests (endoscopies, scans) and even surgeries before someone finally considers CHS. One published case described a patient who had their gallbladder removed to treat supposed cyclical vomiting, but the vomiting continued – only later was heavy cannabis use uncovered as the real cause. Reducing such misdiagnoses will save healthcare costs and spare patients invasive procedures.
-
Treatment Pitfalls: During acute episodes, standard treatments often fail (as discussed), which can frustrate providers and patients. Trial-and-error of medications can take time, and not all hospitals have protocols for CHS. However, more ERs are adopting specific CHS order sets (e.g., giving haloperidol or capsaicin early when CHS is suspected). Another challenge is avoiding giving the patient too many sedatives or narcotics – a balance between relieving suffering and not causing additional problems. Also, if the patient has co-ingestions (some CHS patients might also use other substances) it complicates management.
-
Where Marijuana is Legal: In regions with legal recreational cannabis, there is an interesting dynamic. On one hand, more cases occur because more people use cannabis freely (including daily use). On the other hand, doctors in those areas might be more aware of CHS by necessity. However,
legal markets might be more skeptical of harm (“If it were so bad, it wouldn’t be legal”). Additionally, the cannabis sold legally often has higher THC potency than black-market or older strains. Today’s marijuana concentrates (dabs, oils, high-THC flower) can be extremely potent, potentially increasing CHS risk or severity【23†L236-L244】. Thus, legality can lead to a higher prevalence and potentially more severe cases due to potency. Public health education campaigns in some states now mention CHS as a risk of heavy use – something virtually unheard of a decade ago.
-
Where Marijuana is Used Medically: Some patients using m
na for chronic conditions (like Crohn’s disease or cancer) may develop CHS, which presents a conundrum: the very medicine they rely on is causing illness. Convincing patients and healthcare providers (who recommended cannabis) about CHS can be delicate. Alternative therapies must be found for their original condition, and providers must remain open to the idea that even a “medicine” like cannabis can have adverse effects in some individuals.
-
Research Gaps: Because CHS is relatively new, rigorous research (especially on best treatments) is limited. Most published literature is case reports or small series【6†L133-L141】. There haven’t been large clinical trials to establish the best medication regimen for acute CHS, for instance. This means treatment approaches vary. More research is needed to understand the precise mechanism of CHS and whether any genetic markers predict it – this could lead to targeted therapies or warnings. Also, as cannabis evolves (with new cannabinoids, CBD products, etc.), it’s unknown if those factors influence CHS (for example, does high CBD use mitigate or worsen CHS risk? Not fully known yet).
Despite these challenges, increasing recognition of CHS is a positive development. As both the public and medical community become more aware, patients are being diagnosed more quickly and managed more effectively. In legal-use areas, some emergency departments have even started distributing educational handouts to CHS patients about the condition, and providing resources to help them quit cannabis【8†L31-L37】. Addressing CHS ultimately requires a multidisciplinary approach – emergency care for acute episodes, primary care or gastroenterology for follow-up, and addiction/mental health services for long-term prevention.
Prevention and Rehabilitation: Avoiding CHS and Recovering from Cannabis Dependence
The only sure way to prevent CHS is to avoid heavy, long-term use of cannabis. For the general public and especially for cannabis enthusiasts, this doesn’t mean that every person who smokes will get CHS – far from it. But the risk clearly increases with frequency and duration of use. Here are strategies for prevention and resources for those at risk:
-
Moderation and Monitoring: People who choose to use cannabis should be aware of CHS and monitor their own symptoms. If a person notices unexplained nausea or vomiting episodes and they are a frequent user, they should consider cutting back or taking a break to see if symptoms improve. Sometimes early CHS can be nipped in the bud by reducing use before it progresses. However, evidence suggests that once someone is susceptible, even smaller amounts might eventually trigger it, so the safest course is cessation.
-
Education for Users: Public health messaging (through dispensaries, community health centers, schools, etc.) can include information about CHS. For instance, educational brochures in cannabis dispensaries i
at “regular marijuana use can, in rare cases, lead to severe vomiting illness (CHS).” Just as users are informed about risks like addiction or impair
the radar. Parents of teens should also be aware that if their teen is a heavy cannabis user and has
episodes, CHS could be the reason – encouraging an honest, calm conversation about drug use is
.
-
Rehabilitation Resources: For someone who has experie
), quitting cannabis is imperative. Behavioral therapy is the mainstay: working with
or addiction specialist to develop coping strategies for cravings and to address habits associate
pproaches:
-
Cognitive Behavioral Therapy (CBT): Helps individuals recognize triggers (like cert
r feelings that prompt cannabis use) and develop alternative behaviors. CBT can also
beliefs (“I need cannabis to relax or sleep”) and find healthier substitutions.
-
Mot
Many addiction counselors use MI techniques to strengthen the person’s motivation and commitment to quit by exploring the discrepancy between their goals (health, stability) and their current behavior (using cannabis despite harm).
-
Support Groups: Groups like Marijuana Anonymous (modeled after AA) provide a community of peers who share their experiences quitting cannabis. Hearing success stories and challenges from others can reduce the sense of isolation and provide practical tips. Online forums and local meet-ups exist for those seeking support in quitting marijuana.
-
Outpatient or Inpatient Programs: If cannabis use is very heavy or accompanied by other substance use, structured programs can help. Outpatient drug treatment programs might include weekly counseling, urine testing, and sometimes family therapy. In more severe cases, short-term inpatient rehab (detox programs) provide a cannabis-free environment and intensive counseling – though cannabis withdrawal is not medically dangerous, a structured setting can help break the habit and routine of use.
-
Digital Tools: There are smartphone apps and text-message programs designed to help people quit cannabis. These can provide daily reminders, motivational messages, and track one’s progress in staying abstinent. Some examples include apps like “Quit Cannabis” or government-sponsored texting support lines.
-
-
Medical Aids: Unlike nicotine or opioids, there is no substitution therapy (like a “cannabis patch”) or FDA-approved medication to blunt cannabis cravings. Some doctors may use off-label medications to ease withdrawal symptoms – e.g., short-term use of sleep aids for insomnia, or anxiolytics for severe anxiety (carefully, to avoid replacing one dependence with another). Nutritional support (hydration, vitamins) and exercise can also help the body and mind readjust after quitting.
-
Relapse Prevention: Individuals who quit need strategies to avoid relapse. This may involve changing social routines (if all your friends smoke, it’s tough to stay off; one might need to take a break from those circles or be open about quitting so they can support you). Engaging in new hobbies or activities to fill the time previously spent using cannabis is beneficial – one former CHS patient took up avid reading as a distraction and replacement behavior【25†L329-L337】. Stress management techniques (meditation, exercise, etc.) are important because stress can tempt one back to using. Ongoing therapy or support group attendance provides accountability.
-
Preventing Complications: If someone has had CHS in the past and slips up by using cannabis again, they should be vigilant. At the first sign of nausea, they should seek help or stop immediately. It’s easier to treat a mild recurrence than a full-blown vomiting cycle. Some patients who relapsed keep antiemetic medication or capsaicin cream at home as a stop-gap, but ultimately they know they must cease use again.
For healthcare providers, preventing CHS involves public education and early intervention. If a known heavy cannabis user comes in with any nausea/vomiting complaint, even if mild, providers might counsel them on CHS and suggest a trial of abstinence “just in case.” Catching it in prodromal phase could prevent an ER visit down the line.
Complications of Untreated CHS
CHS, if not recognized and managed, can lead to serious complications mainly due to the effects of persistent vomiting and the behaviors patients adopt:
-
Severe Dehydration: Continuous vomiting causes loss of fluids and inability to keep liquids down, which can result in hypovolemia (low blood volume). If prolonged, dehydration can lead to kidney injury. Indeed, cases of acute renal failure have been reported in CHS patients who were vomiting and taking frequent hot baths (which can further dehydrate by sweating)【34†L1-L4】. The dehydration is “pre-renal,” meaning the kidneys aren’t getting enough blood flow, and if not corrected, it can cause acute kidney failure requiring IV fluids and even dialysis in extreme cases. This is usually reversible with rehydration, but it’s a serious risk.
-
Electrolyte Imbalances: Vomiting causes loss of stomach acid and electrolytes like potassium, sodium, and chloride. Hypokalemia (low potassium) is common in CHS – it can cause muscle weakness, heart rhythm disturbances, and in severe cases, life-threatening arrhythmias. Low magnesium or other electrolytes can trigger seizures or cardiac issues. These imbalances need hospital correction; untreated, they can cause complications like heart rhythm abnormalities or seizures【34†L39-L45】.
-
Esophageal Damage: Repeated forceful vomiting can injure the esophagus. One risk is a Mallory-Weiss tear, which is a tear in the lining of the esophagus that can cause bleeding (vomiting blood). An even rarer but more dangerous injury is esophageal rupture (Boerhaave syndrome), a full-thickness tear that is a surgical emergency. While Boerhaave’s is rare, it’s a known complication of intractable vomiting. CHS patients also often experience acid reflux from delayed gastric emptying and vomiting, which can inflame the esophagus.
-
Malnutrition and Weight Loss: If CHS cycles continue, patients may develop malnutrition from poor oral intake. They can lose significant weight, as each episode might drop them several kilograms. Over time, repeated episodes could stunt growth in adolescents or lead to vitamin deficiencies.
-
Aspiration Pneumonia: Vomiting a lot carries the risk of inhaling vomit into the lungs (especially if the person becomes semi-conscious or is lying down). This can cause aspiration pneumonia or even choking. While not common, any condition with frequent vomiting has this potential risk.
-
Rhabdomyolysis: In some severe cases, dehydration and muscle strain from constant retching can lead to rhabdomyolysis – breakdown of muscle tissue that releases proteins into the blood, which can further hurt the kidneys【34†L33-L40】. This has been noted in a few CHS case reports.
-
Psychological Distress: The experience of CHS can be traumatic. Patients often describe it as terrifying to not know why they were so sick. It can cause anxiety about future episodes or PTSD-like symptoms around vomiting. Additionally, being forced to quit cannabis suddenly can lead to psychological withdrawal (irritability, depression). All these can affect mental health if not addressed.
-
Death: CHS itself is seldom directly fatal, but in extreme cases, complications can lead to death. There have been reports of at least two deaths attributed to CHS complications【37†L258-L262】 – likely due to severe dehydration and electrolyte derangements causing cardiac arrest. These are exceedingly rare outcomes and typically occur if the condition goes unrecognized or the person does not get medical help in time. With proper care (IV fluids, monitoring), fatalities are preventable. Nonetheless, the possibility underscores that CHS is not benign and needs proper medical attention.
The good news is that once CHS is identified, these complications are largely avoidable. Treatment with fluids, electrolyte repletion, and stopping the vomiting will prevent most serious outcomes. The most important “complication” to avoid is recurrence – because each new episode carries the same risks. That’s why abstinence and preventive care are key.
Conclusion
Cannabis Hyperemesis Syndrome serves as a stark reminder that even natural or commonly used substances like marijuana can have unexpected severe side effects in certain individuals. CHS is a preventable and treatable condition, but only if it’s recognized. For long-term cannabis users, the syndrome’s message is cautionary: listen to your body’s signals. Persistent nausea and vomiting should not be ignored or continually self-treated with more cannabis – this may be a vicious cycle leading to worsening illness. For healthcare providers, staying updated on CHS is crucial, especially in today’s era of increasing cannabis use. A timely diagnosis can save patients from unnecessary suffering and medical expenses.
In summary, Cannabis Hyperemesis Syndrome (CHS) is characterized by cyclic episodes of vomiting in chronic marijuana users, driven by a paradoxical effect of the drug on the gut and brain. It unfolds in prodromal, hyperemetic, and recovery phases, and it overwhelmingly improves with cessation of cannabis. Awareness is spreading globally as cases rise. By educating cannabis users about CHS, promoting early diagnosis, and providing support for quitting cannabis, we can mitigate the impact of this syndrome.
While cannabis remains a source of relief and enjoyment for many, CHS is a serious condition that any heavy user should know about. If you or someone you know uses marijuana regularly and has unexplained vomiting bouts, consider CHS and seek medical advice. The solution, though challenging for some, is straightforward – stop cannabis use and stay stopped. The body has an amazing capacity to heal once the offending agent is removed, and in the case of CHS, a full recovery and return to a nausea-free life is not just possible but expected. It all starts with recognizing the signs and making that critical lifestyle change. Stay informed, stay cautious, and health will return – a clear-headed triumph over a troubling syndrome brought on by the very substance once thought to cure it.
Sources:
-
Sorensen CJ, DeSanto K, Borgelt LM, et al. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment【6†L162-L170】【6†L139-L147】. Journal of Medical Toxicology. 2017.
-
Habboushe J, et al. The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana Smokers【27†L317-L324】【27†L319-L327】. Basic Clin Pharmacol Toxicol. 2018.
-
ACEP Toxicology Section. Cannabinoid Hyperemesis Syndrome【4†L75-L84】【4†L81-L85】. April 2024.
-
Cedars-Sinai Medical Center. Cannabis Hyperemesis Syndrome (Patient Guide)【17†L161-L169】【17†L187-L195】.
-
PBS NewsHour – D. Cain. Experts say CHS is on the rise【23†L208-L216】【25†L273-L280】. Oct 2023.
-
UCHealth – T. Neff. Leading cause of marijuana-related ER visits is CHS【42†L79-L87】. Oct 2024.
-
Contreras-Carol et al. Cannabinoid Hyperemesis Syndrome: Case Series and Review【33†L319-L327】【33†L321-L329】. Adicciones. 2016.
-
RCEM (UK) 2023 Guideline. Suspected Cannabinoid Hyperemesis Syndrome in ED【8†L19-L27】【8†L31-L37】.
-
Wang GS, et al. Impact of Cannabis Legalization on Vomiting-Related ED Visits【29†L342-L350】【29†L353-L358】. JAMA Netw Open. 2021.
-
Yoo JW, et al. Trends of CHS-related ED visits in Nevada【38†L323-L331】【38†L325-L332】. PLOS ONE. 2024.
SEO Title: Cannabis Hyperemesis Syndrome (CHS): The Paradox of Marijuana-Induced Vomiting
**
nnabis-hyperemesis-syndrome-chs-explained
Related Keyphrases: cannabinoid hyperemesis syndrome (CHS), marijuana vomiting syndrome, cannabis hyperemesis symptoms, CHS treatment and recovery, long-term cannabis use effects
Tags: Cannabis, Marijuana, Hyperemesis, Vomiting, Gastroenterology, Substance Abuse, Nausea, Public Health
yperemesis Syndrome (CHS): A Cautionary Guide for Cannabis Users and Healthcare Providers
Cannabis Hyperemesis Syndrome (CHS) is a paradoxical illness seen in long-term, frequent marijuana users, causing recurrent bouts of severe nausea, vomiting, and abdominal pain【17†L161-L169】【42†L83-L91】. It might sound counterintuitive – after all, cannabis is often known for
** effects – yet CHS flips the script, leading to what some have dubbed “the marijuana vomiting syndrome.” This comprehensive report explores CHS in detail, from its causes and symptoms to diagnosis, treatment, and prevention, with a cautionary tone aimed at users, medical professionals, and concerned families.
【2†embed_image】 Cannabinoid Hyperemesis Syndrome in
arizing pathophysiology, key diagnostic criteria, phases, and treatments (Source: Sanché Mabins, Cook County Health). Long-term cannabis use can alter the body’s response to the drug, ultimately triggering cycles of intense vomiting despite marijuana’s usual antiemetic reputation【17†L187-L195】【25†L275-L283】. CHS typical
in people who have used cannabis heavily for years** (often daily for a decade or more)【17†L161-L169】【42†L83-L91】. Researchers first identified CHS in 2004 in Australia, and cases have since risen with the increasing prevalence and potency of cannabis worldwide【31†L109-L117】【23†L236-L244】
uide, we break down the syndrome’s three phases (prodromal, hyperemetic, recovery), examine why it happens, discuss h
and treat it, and provide global insights, statistics, and prevention strategies.
What is Cannabis Hyperemesis Syndrome?
Cannabis Hyperemesis Syndrome (CHS) is a condition in which a person experiences repe
of intractable nausea and vomiting due to long-term, high-frequency cannabis use【17†L161-
L140】. It is considered a form of cyclic vomiting disorder triggered specifically by cannabis. CHS occurs exclusively in people with
chronic marijuana use, especially those using daily or multiple times a week over long periods【17†L177-L180】【4†L81-L84】. It often takes years of heavy use before CHS first appears – one hospital observed symptoms after an average of 10–12 years of cannabis use【17†L161-L169】. Unlike the well-known a
efits of cannabis in conditions like chemotherapy-related nausea, CHS is a paradoxical reaction where the same drug causes relentless vomiting.
Causes: The exact cause of CHS remains under investigation, but it is linked to **physiological changes from prolonged
Tetrahydrocannabinol (THC), the primary psychoactive component of cannabis, acts on cannabinoid receptors (CB1 re
both in the brain and the digestive tract【17†L169-L175】. Over time, heavy cannabis use may lead to desensitiza
ulation of these receptors. In the brain, THC initially suppresses nausea (hence its medical use as an antiemetic), but chronic use might cause the brain to stop responding in the same way, reversing marijuana’s anti-nausea effects【17†L187-L195】. Meanwhile, in the gut, THC continuously binding to receptors can slow gastric emp
ct the esophagus and digestion, promoting nausea and reflux【17†L169-L175】【31†L117-L125】. Rese
cribe a “biphasic” effect of cannabinoids: low doses curb nausea, but high chronic doses can trigger nausea and vomiting【15†L130-L139】. Essentially, long-term cannabis use “flips the switch” – the body’s respon
from antiemetic to pro-emetic. Genetic factors may also make some individuals more susceptible; for example, atypical cannabinoid metabolism or variations in receptors could predispose certain people to develop CHS while others never do【37†L273-L282】【37†L287-L295】. It remains unclear why only some heavy marijuana users get CHS and others do not【17†L196-L199】,
examining differences in metabolism, receptor genetics, and other risk factors.
Who is affected: CHS is notoriously associated with long-term, frequent cannabis users – typically those who consume marijuana at least weekly,
ly【17†L177-L180】. Many patients are young adults who began using in their teens or early twenties and continued for years. Heavy use is the key risk factor, and cases have been reported in both recreational and medicinal users of cannabis. There is a notable
– studies indicate around 72–73% of CHS cases occur in males【4†L81-L84】 – though it can affect any gender. The typical age range is 18 to 40 years old, aligning with the demographic of frequent cannabis users【31†L103-L110】. CHS has been observed across different ethnicities and regions, anywhere cannabis use is common. Importantly, only stopping cannabis use can prevent CHS episodes; continued use will perpetuate the cycle【33†L315-L324】【19†L229-L237】.
Phases and Symptoms of CHS
CHS symptoms tend to follow a cyclical pattern. Healthcare providers often divide the syndrome’s course into three phases: the prodromal phase, the hyperemetic phase, and the recovery phase【17†L201-L209】. Each phase has distinctive features:
Prodromal Phase (Pre-Vomiting)
In the prodromal phase, **early warning
e, though they can be subtle. The person may experience persistent morning nausea, occasional stomach pain, and a fear or anxiety about vomiting【17†L207-L215】【35†L208-L216】. Symptoms are milder in this stage and no severe vomiting has started yet. Often, the individual still eats normally, though they might feel queasy especially after waking up【17†L207-L215】. Para
y people in this phase increase their cannabis use under the bel
rijuana will settle their stomach (since it used to help their nausea)【17†L207-L215】. This self-treatment actually perpetuates the cycle. The prodromal phase can last months or even years【17†L207-L215】. Because the symptoms are not acute, individuals might not
stage. They may not realize these intermittent nausea bouts are related to cannabis. There are usually no com
athing behaviors yet in this phase (those come later once vomiting hits). This phase is essentially the calm before the storm, and unfortunately many continue regu
ngly setting the stage for the next phase.
Hyperemetic Phase (Vomiting Crisis)
The hyperemetic phase is when CHS fully manifests. It is characterized by unrelen
episodes of vomiting (hyperemesis), and intense abdominal pain【17†L213-L221】【35†L219-L228】. Vomiting can
and frequent** – patients often retch or vomit multiple times per hour, unable to keep food down. The bouts of
last for 24–48 hours or even days at a time【35†L219-L227】. People in this phase often stop eating and drinking voluntarily because of severe nausea and fear that any intake will provoke vomiting【35†L219-L227】. Weight loss and dehydration are common as a result【35
also develop abdominal tenderness or pain that can be quite severe【17†L213-L221】. A distinctive behavior in this phase is compulsive hot bathing or showering. Patients discover that hot showers or baths dramatically relieve their nausea and abdominal pain, albeit temporarily【19†L220-L228】【35†L229-L237】. They may spend hours in
nd often describe the relief as “temperature-dependent” – the hotter the water, the more the symptoms ease【35†L229-L237】. This behavior is so characteristic that it serves as a clinical clue for CHS: many as 50% or more of CHS patien
ers【2†L0-L0】【19†L271-L279】. (The likely reason is that heat stimuli trigger certain receptors (TRPV1) and the brain’s hypothalamus, which can modulate the vomiting reflex and pain sensation, essentially “distracting” the brain from nausea signals【23†L256-L264】.) During the hyperemetic phase, individuals are usually miserable and incapacitated – unable to work or go about normal life – and often seek medical care due to the uncontrolled vomiting. It is at this stage that most patients end up in emergency departments, sometimes confused with a stomach bug or other acute illness. The hyperemetic phase continues until cannabis use is completely stopped【19†L229-L237】. If the person does not quit, they can cycle in and out of this phase repeatedly. Epi
eeks or months, often triggered by resumption of cannabis or stress.
Recovery Phase (Resolution)
The recovery phase of CHS begins once the individual abstains from cannabis and the acute vomiting episode resolves【19†L229-L237】. During recovery, symptoms gradually go away and normal appetite returns【19†L232-L239】. This phase can last from days to months, depending on how long the person remains cannabis-free and how quickly their body readjusts【
n report feeling significantly better within about 1–2 days after stopping cannabis, with steady improvement thereafter【19†L283-L291】【25†L
y can resume normal eating and hydration, and any weight lost may be regained【35†L240-L248】. Importantly, if the person uses marijuana again, the symptoms almost invariably return, usually after so
use【19†L232-L239】【35†L240-L248】. Relapse is common if the individual believes they are “cured” and can resume even moderate cannabis use – often, the cycle of nausea will start again after a latency period. During recovery, the compulsive hot bathing behavior subsides as it’s no longer needed for symptom relief【35†L240-L248】. Full recovery *requires complete cannabis
ny patients, once they have gone through the ordeal of CHS, are counseled to avoid cannabis permanently to prevent future episodes. This phase is essentially the period of healing and return to baseline health, which can be sustained indefinitely if no further cannabis is used. In some reports, patients needed a few weeks to a
abstinence for all symptoms to fully resolve【35†L240-L248】. Supportive care and counseling during this phase can help maintain abstinence and address any During recovery, the compulsive hot bathing behavior subsides as it’s no longer needed for relief【35†L240-L248】. Supportive care and counseling during this phase can help maintain abstinence and address any underlying issues (such as cannabis dependence or the original reason the person was using marijuana, like anxiety or pain). Education is crucial so that patients understand that resuming cannabis will likely cause symptoms to return【35†L244-L253】.
Summary of CHS Phases: In summary, CHS starts with a prodromal period of milder nausea, escalates into a hyperemetic crisis of vomiting and abdominal pain (often prompting medical care), and then enters a recovery period once cannabis use is halted. This cyclic nature – well periods alternating with debilitating vomiting episodes – is a hallmark of the syndrome【17†L201-L209】. Recognizing these phases can aid in diagnosis and management, a
xt.
Diagnosing CHS: A Clinical Challenge
Diagnosing Cannabis Hyperemesis Syndrome can be challenging because its symptoms mimic those of many other disorders. There is no specific lab test or marker for CHS – diagnosis is clinical, based on history and exclusion of other causes【19†L275-L279】. Physicians must have a high index of suspicion, especially in areas where cannabis use is common. Key steps in the diagnostic process include:
-
Detailed Patient History: A thorough review of the patient’s substance use is critical. Doctors should explicitly ask about cannabis use, including frequency and duration【19†L265-L273】. Often CHS patients have been using marijuana daily or nearly daily for years. Unfortunately, patients may not always volunteer this information due to stigma or not realizing it’s relevant. Cr
dgmental environment (as many emergency physicians advise) encourages honesty【8†L21-L29】. If the person meets the profile – long-term heavy cannabis use – and has cyclic vomiting, CHS is strongly suspected【19†L265-L273】.
-
Clinical Criteria: Doctors look for the characteristic features: long-term cannabis use, severe cyclic vomiting with abdominal pain, and relief of symptoms with hot showers or cessation of cannabis【19†L265-L273】. The relief with hot bathing is a telling clue (few other conditions prompt that behavior)【19†L271-L
he only way to confirm CHS is to see the patient improve after quitting cannabis, since there’s no definitive blood test【19†L275-L279】. In fact, a “diagnostic trial”
is sometimes used – if vomiting stops when cannabis is stopped, CHS is the likely diagnosis.
-
Excluding Other Causes: Because persistent vomiting has many possible causes, healthcare providers will perform tests to rule out other emergencies and disorders【19†L242-L251】. This usually includes blood tests (to check for infection, organ function, electrolyte levels), imaging like abdominal CT or ultrasound (to exclude bowel obstruction, gallbladder disease, kidney stones, etc.), and sometimes an upper endoscopy to look inside the stomach【19†L242-L251】【19†L252-L260】. Women will often get a pregnancy test, since hyperemesis gravidarum (severe vomiting in pregnancy) can mimic CHS【19†L245-L252】. Neurological causes (like brain tumors or migraines) might be evaluated with a CT scan of the head if indicated【19†L252-L260】. Typically, in CHS patients, these tests come back normal, which can further point toward a functional cause like CHS.
-
Differentiating from
ng Syndrome (CVS): CHS is often initially misdiagnosed as Cyclic Vomiting Syndrome, a disorder with similar bouts of vomiting but usually without the cannabis connection【19†L258-L264】. In fact, many CHS patients c
gnosis until the truth comes out about cannabis use【4†L91-L99】. One distinction is that CVS sufferers may or may not use cannabis, and their vomiting episodes have defined frequency criteria, whereas CHS diagnostic criteria hinge on cannabis use history and behaviors like hot bathing【4†L93-L99】. If a patient is eventual
ut using marijuana heavily, or if doctors clue in to the hot shower habit, the diagnosis often shifts to CHS. On average, studies have found a significant delay in diagnosing CHS – often over 1–2 years from symptom onset – during which patients may undergo multiple ER visits, hospital admissions, and invasive tests【4†L89-L97】【33†L321-L329】. This delay is usually due to lack of awareness and pati
cannabis use.
Because CHS was only relatively recently recognized (since the early 2000s), some healthcare providers are still unfamiliar with it【19†L258-L264】. Increasing awareness is improving diagnosis. For instance, emergency medici
in the UK in 2023 urge clinicians to consider CHS in any cyclic vomiting case with cannabis use and to pro
ation and support for quitting if CHS is suspected【8†L19-L27】【8†L31-L37】. Ultimately, an accurate d
s on recognizing the pattern (chronic cannabis use + cyclic vomiting + hot shower relief) and taking the patient’s word seriously when they report their cannabis habits and self-relief behaviors. When CHS is correctly dia
n be avoided and appropriate treatment can begin.
Treatment: Managing an Active CHS Episode and Long-Term Recovery
Immediate
ent: During an active CHS episode (the hyperemetic phase), the focus is on stabilizing the patient and relieving symptoms. The cornerstone of acute treatment is **suppo
*:
-
Rehydration: Profuse vomiting causes dehydration and electrolyte imbalances, so patients often need IV fluids to rehydrate and IV electrolyte replacements (such as potassium) if levels are low【25†L268-L276】.
ress dizziness, weakness, or kidney strain from dehydration.
-
Antiemetic Medications: Paradoxically, standard anti-vomiting drugs (antiemetics) that wor
types of nausea often have little effect in CHS. Medications like ondansetron (Zofran) or metoclopramide are commonly tried but frequently ineffective against CHS-rel
Patients typically do not respond to these conventional treatments【4†L79-L84】. Instead, some other medications have shown better results:
-
Benzodiazepines: Drugs suc
help by sedating the patient and reducing the anxiety and vomiting cycle. Sedation can break the stress-vomit feedback loop and provide relief【6†L128-L136】【6†L138-L142】. Caution is used due to their addictive potential, especially since CHS patients may have substance use issues【6†L134-L141】.
-
Haloperidol or Droperidol: These antipsychotic medications (used here
or nausea) have shown efficacy in relieving CHS vomiting in many cases【6†L126-L134】【6
Haloperidol, given intravenously, often calms vomiting when other drugs fail, as in the emergency scenario described where a patient’s nausea resolved with IV haloperidol【4†L59-L67】【4†L81-L84】. Droperidol has also been used; although formal research is limited, some ER protocols includ
6†L152-L160】. (Droperidol was previously less available due to safety concerns but is making a comeback in nausea treatment【6†L152-L160】.)
-
Topical Capsaicin: Interestingly, capsaicin cream (applied to the skin) has emerged as a novel treatment for CHS. Rubbing capsaicin (chili pepper extract) on the abdomen can stimulate the same receptors (TRPV1) activated by heat, mimicking the hot-shower effect【19†L291-L29
atients, capsaicin cream significantly reduces nausea and vomiting. It’s a simple, non-invasive therapy now recommended in many eme
S.
-
Other Medications: Doctors have experimented with various drugs: **Tricyclic antidepressants (TCAs)
een noted to help some CHS patients【25†L273-L280】 (and can be useful for prevention in chronic cases); anticholin
opolamine, antihistamines like diphenhydramine, or even NK1 antagonists like aprepitant (used for ch
iting) have been tried with mixed success【6†L130-L138】【6†L132-L140】. There’s no single guaranteed drug cure, and often a cocktail is used.
-
-
Pain Control: Abdominal
ense. Depending on severity, patients may receive pain relief medications. NSAIDs or acetaminophen are used if possible; in severe cases, opioi
ven sparingly, but clinicians try to avoid them due to the risk of worsening nausea and adding another dependency.
-
Thermal Treatment: Encouragin
nt to continue hot showers or hot baths (if feasible in the hospital) can be part of symptomatic treatment
ometimes warm blankets or heating pads are provided to simulate the effect. As mentioned, topical capsaicin can be an easier substitute for hot water immersion and has become an evidence-supported therapy【19†L291-L298】【6†L137-L140
iting is so severe that oral medications can’t be kept down, all medicines are given intravenously. Patients with uncontrolled vomiting and dehydration often require hospital admission for 24-48 hours until symptoms are under c
the hospital, they will be monitored for electrolyte disturbances (e.g., low potassium which can affect the heart) and kidney function, given continuous IV fluids, and medicated as above until the vomiting stops【25†L268-L276】【25†L270-L277】. In almost all cases, symptoms begin to improve within a day or two once cannabis use is stopped and supportive treatment is underway【19†L283-L291】.
Abstinence – The Only Definitive Cure: No matter what acute treatments are given, doctors and patients consistently find that the only way to truly resolve CHS is to sto
is entirely【25†L275-L283】. During an episode, patients are advised (and often too sick) to not consume any more marijuana. Once they recover, long-term management is complete cessation of cannabis. As Dr. Camilleri (a gastroenterologist) noted, “Ultimately, the only way to guarantee health is by totally abstaining [from cannabis]. If the patient quits, vomiting due to CHS largely subsides”【25†L273-L280】. Continued or resumed marijuana use will likely trigger another cycle of illness. Some patients ask if they can go back to using a smaller amount or a weaker cannabis product. The consensus is that even lower amounts or frequency can risk recurrence, and science hasn’t confirmed any “safe” level of use for someone who has had CHS【25†L277-L284】. Therefore, complete quitting is strongly recommended.
Long-Term Recovery and Support: After the acute phase has passed and the patient is no longer vomiting, the focus shifts to maintaining abstinence and recovering fully:
-
Patients are educated that CHS will return if they resume cannabis.
n referred to follow up with their primary care physician or a gastroenterologist and, importantly, to addiction specialists or counselors if cannabis use disorder is a conce
se many CHS sufferers used cannabis to self-medicate for other problems (such as anxiety, depression, or chronic pain), it’s important to treat those underlying issues separately. For example, if a patient used marijuana for anxiety relief, a physician might prescribe alternative anxiolytics or recommend therapy so the patient isn’t tempted to turn back to cannabis.
-
Psychological and B
herapies: Quitting cannabis after years of use can be difficult. Patients might experience withdrawal symptoms like irritability, insomnia, and cravings【25†L290-L298】. Referral to therapy can help. Cognitive Behavioral Therapy (CBT) and motivational enhancement therapy have been used to support cannabis cessation. Some patients find help in 12-step programs or support groups (like Marijuana Anonymous or other substance abuse support networks) – sharing experiences and strategies can reinforce their resolve.
-
Follow-up Medication: There is no specific medication to “prevent” CHS aside from not using cannabis. However, if needed, doctors might prescribe a low-dose antiemetic or acid suppressor to have on hand in case of mild nausea during early abstinence. In some cases, if a patient absolutely cannot stop vomiting without cannabis (a very rare scenario in chronic refractory cyclic vomiting), doctors have explored using amitriptyline or other prophylactic meds long-term【25†L273-L280】, but again, these are adjuncts and not a substitute for abstinence.
-
Nutritional support: After severe episodes, patients may be malnourished or have food aversions. Dietitians might get involved to help gradually restore a normal diet and ensure proper nutrition and hydration during recovery.
It’s worth noting that cannabis use disorder (CUD) often coexists with CHS. In fact, by definition CHS patients have been using heavily despite harm, which meets criteria for CUD. Up to 20-30% of regular marijuana users develop a use disorder【25†L299-L307】, and
by nature tend to be in that heavy-use bracket. Unfortunately, there are no highly effective medications to treat cannabis addiction at this time【25†L301-L307】. Treatment relies on counseling, behavioral interventions, and social support. Some research is ongoing into medications (like certain antidepressants or anticonvulsants) to ease cannabis withdrawal or reduce cravings, but none are standard yet. Thus, behavioral therapy and support networks are the mainstay to help CHS patients stay off cannabis for good.
Outcome: With sustained abstinence, the long-term outlook for CHS patients is excellent – they typically have no further episodes and return to completely normal health. The challenge is maintaining that abstinence. Education and follow-up are crucial. Many patients, after suffering the ordeal of CHS, are motivated to quit. In interviews, recovered patients often emphasize how much better they feel and caution others not to risk even occasional use. As one recovered CHS patient advised, “Stop completely. Don’t think continuing with small amounts will help you, because it’s not. You need to just stop”【25†L331-L339】.
Prevalence and Trends: How Common is CHS?
When
st recognized in 2004, it was thought to be extremely rare. For years, only scattered cases were reported (only 83 cases documented worldwide up to 2014【33†L319-L327】). However, as awareness has grown and cannabis use has increased, we now know CHS is more common than initially believed. Estimating prevalence is tricky because many cases go undiagnosed or unreported. There is no dedicated diagnostic code in medical records for CHS, often being logged simply as generic “vomiting”【42†L98-L105】. Still, emerging data and studies provide insight:
-
A landmark survey-based study in New York aimed to estimate CHS prevalence among frequent cannabis users. It found about 33% of heavy users (using ≥20 days/month) reported experiencing CHS-like symptoms (cyclic vomiting relieved by hot showers). Extrapolated nationally, this suggests roughly 2.7 million Americans may suffer from CHS annually【27†L317-L324】【27†L319-L327】. This shocked many clinicians, as it implied CHS might affect around one-third of very heavy cannabis users – far from a rare fluke.
-
Another
egged the overall prevalence of CHS in the general population at around 0.1%【31†L103-L110】. While that is a small percentage, consider that around 18% of Americans use cannabis at least occasionally【4†L73-L81】. Among daily or long-term users, the risk is much higher (again, up to one-third by some estimates【31†L103-L110】).
-
Demographics: CHS tends to affect younger adults most – typically ages 18–40 as noted. Adolescents can develop CHS as well, especially with the rise of high-potency cannabis and vaping allowing near-constant use by teens【23†L217-L226】【23†L229-L236】. Some pediatric hospitals now report seeing teen CHS cases on a regular basis, whereas it was virtually unseen in youth decades ago【23†L217-L224】. In terms of gender, studies show a male predominance (~70–75% male), though whether males are more biologically prone or simply more likely to be heavy users is unclear【4†L81-L85】.
-
Trends with Legalization: In places with legal recreational cannabis, CHS cases have risen substantially. For example, emergency departments in North America saw CHS visit rates double between 2017 and 2021【23†L208-L216】. Colorado, one of the earliest states to legalize marijuana, experienced a 23% increase in cannabis-related vomiting cases post-legalization in one study【28†L21-L29】. Another study of Colorado ER data (2013–2018) found vomiting-related ER visits climbed 29% after legalization, correlating with the proliferation of cannabis dispensaries【29†L342-L350】【29†L353-L358】. Nevada saw similar trends: the rate of CHS ER visits roughly doubled from about 1.1 per 100,000 people to 2.2 per 100,000 after recreational cannabis commercialization【38†L321-L329】【38†L323-L331】. These trends strongly suggest that as cannabis use becomes more widespread, CHS follows in step.
-
Healthcare Impact: In areas with heavy marijuana use, CHS has become a nota
emergency care. In fact, in Colorado, CHS is now the leading cause of marijuana-related ER visits – more common than ER visits for cannabis intoxication or anxiety reactions【42†L79-L87】. At one large hospital, doctors reported seeing 1-2 CHS patients every day in the ER【42†L99-L105】. This translates to significant healthcare costs and resource utilization. One study estimated the financial burden of CHS on the US healthcare system was rising, with thousands of ER visits annually attributable to the syndrome (though exact dollar figures are still being researched)【6†L162-L170】.
To illustrate some key statistics about CHS, see Table 1 below.
| CHS Statistic | Value / Observation |
|---|---|
| Onset after prolonged use | Typica
ears** of heavy cannabis use (often >1 year daily; ~10 years on average)【17†L161-L169】【42†L83-L91】. |
| Affected population | Long-term, frequent marijuana users; most often age 18–40; ~73% of cases are male【4†L81-L84】【31†L103-L110】. |
| Prevalence among heavy users | Up to 32–33% of very heavy cannabis users may experience CHS【27†L317-L324】【31†L103-L110】. |
| Estimated annual cases (U.S.) | ~2.75 million Americans may suffer CHS each year (extrapolated)【27†L319-L327】. |
| Trend in ER visits (North America) | 2× increase in CHS-related ER visits from 2017 to 2021【23†L208-L216】. Rising cases noted especially where cannabis is legal. |
| Unique diagnostic behavior | ~50%+ of patients use hot showers for relief during episodes【2†L0-L0】【19†L271-L279】 (a key diagnostic clue). |
| Time to diagnosis (historically) | **Delay of year
3–4 years of symptoms) before CHS is recognized【33†L321-L329】, due to misdiagnosis as other illnesses. |
| Male-to-Female ratio | Approximately 3:1 male to female predominance in reported cases【4†L81-L84】. |
| Recurrence risk | High – Symptoms almost always return if cannabis use resumes【19†L232-L239】. Only complete abstinence prevents relapse. |
| Mortality | Rare – CHS is seldom fatal if treated, but complications have led to a few reported deaths (via severe dehydration and organ failure)【37†L258-L262】. |
Table 1: Key facts and figures about Cannabis Hyperemesis Syndrome (CHS).
Globally, as cannabis use rises, CHS likely does as well. The world’s population of regular cannabis users is estimated at about 2.5–5% of people【4†L73-L81】 – that’s hundreds of millions of users – so even a small fraction developing CHS translates to many individuals. In the next section, we’ll explore how CHS is being recognized (or overlooked) in different parts of the world.
International Perspectives: CHS Beyond the U.S.
While much CHS research comes from North America (where cannabis use is high and now often legal), awareness of CHS is spreading internationally:
-
Australia: Australia is where CHS was first identified in 2004, in a case series of 19 patients that put this syndrome on the medical map【31†L109-L117】. Since then, Australia (which has a significant cannabis-using population) has reported numerous cases. Australian emergency physicians are generally aware of CHS today, especially after high-profile publications.
-
Canada: Canada legalized recreational marijuana in 2018, and since then, Canadian hospitals have noted CHS as an emerging issue. Though specific Canadian data is still developing, anecdotal reports from physicians in cities like Toronto and Vancouver indicate more patients presenting with CHS post-legalization, mirroring U.S. trends. One Canadian study prior to legalization already found cannabis was associated with cyclic vomiting cases, and experts expect an uptick. Canadian healthcare guidelines (e.g., by the Canadian Association of Emergency Physicians) now include CHS in differential diagnoses for vomiting.
-
Europe: In Europe, cannabis laws and usage rates vary by country, but CHS cases have been documented across the continent. Spain had reported at least 4 cases by 2014 and published additional ones since【33†L319-L327】. United Kingdom: The UK has had CHS case reports since the 2010s; by 2023, as we saw, a formal guideline for Emergency Departments was released to improve recognition of CHS【8†L19-L27】. This suggests UK clinicians are encountering it enough to warrant official guidance. Some UK hospitals note that CHS is still underdiagnosed – patients often go through many tests before the puzzle pieces (cannabis use + vomiting + hot baths) are put together. Italy, Germany, France: all have published case reports or small series in medical literature describing CHS in their populations【32†L5-L13】. The syndrome is likely under-recognized in countries where cannabis use, while present, is less openly discussed due to legal status. But as those countries move toward more cannabis use (medicinal or recreational), CHS is expected to appear more frequently.
-
Asia and Other Regions: Cannabis use prevalence in Asia is lower in general, but it exists and is growing in some areas. There have been isolated CHS case reports in countries like India and Japan in recent years, albeit very few. Given the illegal status in many Asian countries, users may hide their cannabis use, and doctors may not think of CHS at first. Some travelers from Western countries have been diagnosed with CHS while abroad, confusing local physicians who were unaware of the condition. This highlights a need for global medical education on CHS as cannabis use globalizes.
-
Awareness and Education: Internationally, one challenge is simply lack of awareness among healthcare providers. A patient with CHS in a country where cannabis is not widely used or is taboo might be subjected to extensive invasive testing for rare diseases while the true cause (cannabis) is overlooked. However, the spread of information via medical journals and conferences is improving knowledge. Organizations like the International Cannabinoid Research Society and various gastroenterology associations are now discussing CHS at meetings. The inclusion of CHS as a subset of cyclic vomiting in the Rome IV criteria (a global gastroenterology diagnostic standard) in 2016 also helped legitimize and disseminate the concept【37†L311-L317】.
In summary, CHS is not limited to the U.S. or places with legal weed; it has been observed anywhere chronic cannabis use occurs. But places with higher rates of use (North America, Austr
Europe) have unsurprisingly reported more cases. With cannabis use on the rise globally – both for recreational and medicinal purposes – CHS stands as a cautionary phenomenon worldwide. Countries new to liberalizing cannabis laws may see a surge in CHS cases as a consequence, emphasizing the importance of preparing healthcare systems to recognize and treat this syndrome.
Challenges in Diagnosis and Treatment
CHS poses several challenges to both patients and healthcare systems, especially in contexts of widespread cannabis use:
-
Lack of Awareness and Initial Dismissal: Many patients and even doctors are initially unaware that chronic cannabis use can cause such symptoms. Patients often cannot believe cannabis is the culprit, since they have used it for years to feel good or even to treat nausea. There is often resistance or denial – “Weed helps my stomach, it can’t be making me sick” is a common sentiment. This can lead patients to refuse to accept the diagnosis of CHS【4†L91-L99】. They may continue using cannabis in disbelief, thus continuing the cycle of illness. Similarly, some physicians, unfamiliar with CHS, might attribute the vomiting to more familiar causes and miss the cannabis connection. Overcoming this requires education – doctors need to gently convince patients of the link by explaining the paradoxical physiology and pointing to the hallmark behaviors (like hot showers) and the improvement with abstinence.
-
Stigma and Honesty Issues: In places where marijua
gal or stigmatized, patients may hide their use, leading doctors down the wrong diagnostic path. Conversely, in places where cannabis is lauded for medical benefits, patients might be offended by the suggestion that cannabis is harming them. Striking the right approach is key – clinicians aim to be nonjudgmental and factual: “We know most people tolerate cannabis well, but in some it can cause this syndrome. The good news is it’s reversible if you stop using.” Emphasizing confidentiality (especially in illegal settings) can help patients open up about their habit【8†L21-L29】.
-
Diagnostic Overlap: As mentioned, CHS gets mistaken for gastrointestinal disorders (ulcers, gastritis, gallbladder attacks), eating disorders, pregnancy-related vomiting
tric illness. Some CHS patients undergo multiple expensive tests (endoscopies, scans) and even surgeries before someone finally considers CHS. One published case described a patient who had their gallbladder removed to treat supposed cyclical vomiting, but the vomiting continued – only later was heavy cannabis use uncovered as the real cause. Reducing such misdiagnoses will save healthcare costs and spare patients invasive procedures.
-
Treatment Pitfalls: During acute episodes, standard treatments often fail (as discussed), which can frustrate providers and patients. Trial-and-error of medications can take time, and not all hospitals have protocols for CHS. However, more ERs are adopting specific CHS order sets (e.g., giving haloperidol or capsaicin early when CHS is suspected). Another challenge is avoiding giving the patient too many sedatives or narcotics – a balance between relieving suffering and not causing additional problems. Also, if the patient has co-ingestions (some CHS patients might also use other substances) it complicates management.
-
Where Marijuana is Legal: In regions with legal recreational cannabis, there is an interesting dynamic. On one hand, more cases occur because more people use cannabis freely (including daily use). On the other hand, doctors in those areas might be more aware of CHS by necessity. However,
legal markets might be more skeptical of harm (“If it were so bad, it wouldn’t be legal”). Additionally, the cannabis sold legally often has higher THC potency than black-market or older strains. Today’s marijuana concentrates (dabs, oils, high-THC flower) can be extremely potent, potentially increasing CHS risk or severity【23†L236-L244】. Thus, legality can lead to a higher prevalence and potentially more severe cases due to potency. Public health education campaigns in some states now mention CHS as a risk of heavy use – something virtually unheard of a decade ago.
-
Where Marijuana is Used Medically: Some patients using m
na for chronic conditions (like Crohn’s disease or cancer) may develop CHS, which presents a conundrum: the very medicine they rely on is causing illness. Convincing patients and healthcare providers (who recommended cannabis) about CHS can be delicate. Alternative therapies must be found for their original condition, and providers must remain open to the idea that even a “medicine” like cannabis can have adverse effects in some individuals.
-
Research Gaps: Because CHS is relatively new, rigorous research (especially on best treatments) is limited. Most published literature is case reports or small series【6†L133-L141】. There haven’t been large clinical trials to establish the best medication regimen for acute CHS, for instance. This means treatment approaches vary. More research is needed to understand the precise mechanism of CHS and whether any genetic markers predict it – this could lead to targeted therapies or warnings. Also, as cannabis evolves (with new cannabinoids, CBD products, etc.), it’s unknown if those factors influence CHS (for example, does high CBD use mitigate or worsen CHS risk? Not fully known yet).
Despite these challenges, increasing recognition of CHS is a positive development. As both the public and medical community become more aware, patients are being diagnosed more quickly and managed more effectively. In legal-use areas, some emergency departments have even started distributing educational handouts to CHS patients about the condition, and providing resources to help them quit cannabis【8†L31-L37】. Addressing CHS ultimately requires a multidisciplinary approach – emergency care for acute episodes, primary care or gastroenterology for follow-up, and addiction/mental health services for long-term prevention.
Prevention and Rehabilitation: Avoiding CHS and Recovering from Cannabis Dependence
The only sure way to prevent CHS is to avoid heavy, long-term use of cannabis. For the general public and especially for cannabis enthusiasts, this doesn’t mean that every person who smokes will get CHS – far from it. But the risk clearly increases with frequency and duration of use. Here are strategies for prevention and resources for those at risk:
-
Moderation and Monitoring: People who choose to use cannabis should be aware of CHS and monitor their own symptoms. If a person notices unexplained nausea or vomiting episodes and they are a frequent user, they should consider cutting back or taking a break to see if symptoms improve. Sometimes early CHS can be nipped in the bud by reducing use before it progresses. However, evidence suggests that once someone is susceptible, even smaller amounts might eventually trigger it, so the safest course is cessation.
-
Education for Users: Public health messaging (through dispensaries, community health centers, schools, etc.) can include information about CHS. For instance, educational brochures in cannabis dispensaries i
at “regular marijuana use can, in rare cases, lead to severe vomiting illness (CHS).” Just as users are informed about risks like addiction or impair
the radar. Parents of teens should also be aware that if their teen is a heavy cannabis user and has
episodes, CHS could be the reason – encouraging an honest, calm conversation about drug use is
.
-
Rehabilitation Resources: For someone who has experie
), quitting cannabis is imperative. Behavioral therapy is the mainstay: working with
or addiction specialist to develop coping strategies for cravings and to address habits associate
pproaches:
-
Cognitive Behavioral Therapy (CBT): Helps individuals recognize triggers (like cert
r feelings that prompt cannabis use) and develop alternative behaviors. CBT can also
beliefs (“I need cannabis to relax or sleep”) and find healthier substitutions.
-
Mot
Many addiction counselors use MI techniques to strengthen the person’s motivation and commitment to quit by exploring the discrepancy between their goals (health, stability) and their current behavior (using cannabis despite harm).
-
Support Groups: Groups like Marijuana Anonymous (modeled after AA) provide a community of peers who share their experiences quitting cannabis. Hearing success stories and challenges from others can reduce the sense of isolation and provide practical tips. Online forums and local meet-ups exist for those seeking support in quitting marijuana.
-
Outpatient or Inpatient Programs: If cannabis use is very heavy or accompanied by other substance use, structured programs can help. Outpatient drug treatment programs might include weekly counseling, urine testing, and sometimes family therapy. In more severe cases, short-term inpatient rehab (detox programs) provide a cannabis-free environment and intensive counseling – though cannabis withdrawal is not medically dangerous, a structured setting can help break the habit and routine of use.
-
Digital Tools: There are smartphone apps and text-message programs designed to help people quit cannabis. These can provide daily reminders, motivational messages, and track one’s progress in staying abstinent. Some examples include apps like “Quit Cannabis” or government-sponsored texting support lines.
-
-
Medical Aids: Unlike nicotine or opioids, there is no substitution therapy (like a “cannabis patch”) or FDA-approved medication to blunt cannabis cravings. Some doctors may use off-label medications to ease withdrawal symptoms – e.g., short-term use of sleep aids for insomnia, or anxiolytics for severe anxiety (carefully, to avoid replacing one dependence with another). Nutritional support (hydration, vitamins) and exercise can also help the body and mind readjust after quitting.
-
Relapse Prevention: Individuals who quit need strategies to avoid relapse. This may involve changing social routines (if all your friends smoke, it’s tough to stay off; one might need to take a break from those circles or be open about quitting so they can support you). Engaging in new hobbies or activities to fill the time previously spent using cannabis is beneficial – one former CHS patient took up avid reading as a distraction and replacement behavior【25†L329-L337】. Stress management techniques (meditation, exercise, etc.) are important because stress can tempt one back to using. Ongoing therapy or support group attendance provides accountability.
-
Preventing Complications: If someone has had CHS in the past and slips up by using cannabis again, they should be vigilant. At the first sign of nausea, they should seek help or stop immediately. It’s easier to treat a mild recurrence than a full-blown vomiting cycle. Some patients who relapsed keep antiemetic medication or capsaicin cream at home as a stop-gap, but ultimately they know they must cease use again.
For healthcare providers, preventing CHS involves public education and early intervention. If a known heavy cannabis user comes in with any nausea/vomiting complaint, even if mild, providers might counsel them on CHS and suggest a trial of abstinence “just in case.” Catching it in prodromal phase could prevent an ER visit down the line.
Complications of Untreated CHS
CHS, if not recognized and managed, can lead to serious complications mainly due to the effects of persistent vomiting and the behaviors patients adopt:
-
Severe Dehydration: Continuous vomiting causes loss of fluids and inability to keep liquids down, which can result in hypovolemia (low blood volume). If prolonged, dehydration can lead to kidney injury. Indeed, cases of acute renal failure have been reported in CHS patients who were vomiting and taking frequent hot baths (which can further dehydrate by sweating)【34†L1-L4】. The dehydration is “pre-renal,” meaning the kidneys aren’t getting enough blood flow, and if not corrected, it can cause acute kidney failure requiring IV fluids and even dialysis in extreme cases. This is usually reversible with rehydration, but it’s a serious risk.
-
Electrolyte Imbalances: Vomiting causes loss of stomach acid and electrolytes like potassium, sodium, and chloride. Hypokalemia (low potassium) is common in CHS – it can cause muscle weakness, heart rhythm disturbances, and in severe cases, life-threatening arrhythmias. Low magnesium or other electrolytes can trigger seizures or cardiac issues. These imbalances need hospital correction; untreated, they can cause complications like heart rhythm abnormalities or seizures【34†L39-L45】.
-
Esophageal Damage: Repeated forceful vomiting can injure the esophagus. One risk is a Mallory-Weiss tear, which is a tear in the lining of the esophagus that can cause bleeding (vomiting blood). An even rarer but more dangerous injury is esophageal rupture (Boerhaave syndrome), a full-thickness tear that is a surgical emergency. While Boerhaave’s is rare, it’s a known complication of intractable vomiting. CHS patients also often experience acid reflux from delayed gastric emptying and vomiting, which can inflame the esophagus.
-
Malnutrition and Weight Loss: If CHS cycles continue, patients may develop malnutrition from poor oral intake. They can lose significant weight, as each episode might drop them several kilograms. Over time, repeated episodes could stunt growth in adolescents or lead to vitamin deficiencies.
-
Aspiration Pneumonia: Vomiting a lot carries the risk of inhaling vomit into the lungs (especially if the person becomes semi-conscious or is lying down). This can cause aspiration pneumonia or even choking. While not common, any condition with frequent vomiting has this potential risk.
-
Rhabdomyolysis: In some severe cases, dehydration and muscle strain from constant retching can lead to rhabdomyolysis – breakdown of muscle tissue that releases proteins into the blood, which can further hurt the kidneys【34†L33-L40】. This has been noted in a few CHS case reports.
-
Psychological Distress: The experience of CHS can be traumatic. Patients often describe it as terrifying to not know why they were so sick. It can cause anxiety about future episodes or PTSD-like symptoms around vomiting. Additionally, being forced to quit cannabis suddenly can lead to psychological withdrawal (irritability, depression). All these can affect mental health if not addressed.
-
Death: CHS itself is seldom directly fatal, but in extreme cases, complications can lead to death. There have been reports of at least two deaths attributed to CHS complications【37†L258-L262】 – likely due to severe dehydration and electrolyte derangements causing cardiac arrest. These are exceedingly rare outcomes and typically occur if the condition goes unrecognized or the person does not get medical help in time. With proper care (IV fluids, monitoring), fatalities are preventable. Nonetheless, the possibility underscores that CHS is not benign and needs proper medical attention.
The good news is that once CHS is identified, these complications are largely avoidable. Treatment with fluids, electrolyte repletion, and stopping the vomiting will prevent most serious outcomes. The most important “complication” to avoid is recurrence – because each new episode carries the same risks. That’s why abstinence and preventive care are key.
Conclusion
Cannabis Hyperemesis Syndrome serves as a stark reminder that even natural or commonly used substances like marijuana can have unexpected severe side effects in certain individuals. CHS is a preventable and treatable condition, but only if it’s recognized. For long-term cannabis users, the syndrome’s message is cautionary: listen to your body’s signals. Persistent nausea and vomiting should not be ignored or continually self-treated with more cannabis – this may be a vicious cycle leading to worsening illness. For healthcare providers, staying updated on CHS is crucial, especially in today’s era of increasing cannabis use. A timely diagnosis can save patients from unnecessary suffering and medical expenses.
In summary, Cannabis Hyperemesis Syndrome (CHS) is characterized by cyclic episodes of vomiting in chronic marijuana users, driven by a paradoxical effect of the drug on the gut and brain. It unfolds in prodromal, hyperemetic, and recovery phases, and it overwhelmingly improves with cessation of cannabis. Awareness is spreading globally as cases rise. By educating cannabis users about CHS, promoting early diagnosis, and providing support for quitting cannabis, we can mitigate the impact of this syndrome.
While cannabis remains a source of relief and enjoyment for many, CHS is a serious condition that any heavy user should know about. If you or someone you know uses marijuana regularly and has unexplained vomiting bouts, consider CHS and seek medical advice. The solution, though challenging for some, is straightforward – stop cannabis use and stay stopped. The body has an amazing capacity to heal once the offending agent is removed, and in the case of CHS, a full recovery and return to a nausea-free life is not just possible but expected. It all starts with recognizing the signs and making that critical lifestyle change. Stay informed, stay cautious, and health will return – a clear-headed triumph over a troubling syndrome brought on by the very substance once thought to cure it.
Sources:
-
Sorensen CJ, DeSanto K, Borgelt LM, et al. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment【6†L162-L170】【6†L139-L147】. Journal of Medical Toxicology. 2017.
-
Habboushe J, et al. The Prevalence of Cannabinoid Hyperemesis Syndrome Among Regular Marijuana Smokers【27†L317-L324】【27†L319-L327】. Basic Clin Pharmacol Toxicol. 2018.
-
ACEP Toxicology Section. Cannabinoid Hyperemesis Syndrome【4†L75-L84】【4†L81-L85】. April 2024.
-
Cedars-Sinai Medical Center. Cannabis Hyperemesis Syndrome (Patient Guide)【17†L161-L169】【17†L187-L195】.
-
PBS NewsHour – D. Cain. Experts say CHS is on the rise【23†L208-L216】【25†L273-L280】. Oct 2023.
-
UCHealth – T. Neff. Leading cause of marijuana-related ER visits is CHS【42†L79-L87】. Oct 2024.
-
Contreras-Carol et al. Cannabinoid Hyperemesis Syndrome: Case Series and Review【33†L319-L327】【33†L321-L329】. Adicciones. 2016.
-
RCEM (UK) 2023 Guideline. Suspected Cannabinoid Hyperemesis Syndrome in ED【8†L19-L27】【8†L31-L37】.
-
Wang GS, et al. Impact of Cannabis Legalization on Vomiting-Related ED Visits【29†L342-L350】【29†L353-L358】. JAMA Netw Open. 2021.
-
Yoo JW, et al. Trends of CHS-related ED visits in Nevada【38†L323-L331】【38†L325-L332】. PLOS ONE. 2024.
Related Videos:
Related Posts:
Medical Spider: Your Ultimate Symptom Checker
Broken Heart Syndrome and Its Impact on Caregivers: A Silent Health Crisis
Comprehensive Guide to Troubleshooting Bluetooth Connectivity Issues in Windows
Self-Care Shenanigans: A Hilariously Honest Guide to Finding Your Zen Amidst the Chaos
Escape Key Not Found: The Hilariously True Story of a Keyboard Warrior
Related Posts
About the Author: Bernard Aybout (Virii8)
